title: Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb.
abstract: Ischemia induces both hypoxia and inflammation that trigger angiogenesis. The inflammatory reaction is modulated by production of anti-inflammatory cytokines. This study examined the potential role of a major anti-inflammatory cytokine, interleukin (IL)-10, on angiogenesis in a model of surgically induced hindlimb ischemia. Ischemia was produced by artery femoral occlusion in both C57BL/6J IL-10(+/+) and IL-10(-/-) mice. After 28 days, angiogenesis was quantified by microangiography, capillary, and arteriole density measurement and laser Doppler perfusion imaging. The protein levels of IL-10 and vascular endothelial growth factor (VEGF) were determined by Western blot analysis in hindlimbs. IL-10 was markedly expressed in the ischemic hindlimb of IL-10(+/+) mice. Angiogenesis in the ischemic hindlimb was significantly increased in IL-10(-/-) compared with IL-10(+/+) mice. Indeed, angiographic data showed that vessel density in the ischemic leg was 10.2+/-0.1% and 5.7+/-0.4% in IL-10(-/-) and IL-10(+/+) mice, respectively (P:<0.01). This corresponded to improved ischemic/nonischemic leg perfusion ratio by 1.4-fold in IL-10(-/-) mice compared with IL-10(+/+) mice (0.87+/-0. 05 versus 0.63+/-0.01, respectively; P:<0.01). Revascularization was associated with a 1.8-fold increase in tissue VEGF protein level in IL-10(-/-) mice compared with IL-10(+/+) mice (P:<0.01). In vivo electrotransfer of murine IL-10 cDNA in IL-10(-/-) mice significantly inhibited both the angiogenic process and the rise in VEGF protein level observed in IL-10(-/-) mice. No changes in vessel density or VEGF content were observed in the nonischemic hindlimb. These findings underscore the antiangiogenic effect of IL-10 associated with the downregulation of VEGF expression and suggest a role for the inflammatory balance in the modulation of ischemia-induced angiogenesis.
authors.affiliation: INSERM U541, Hôpital Lariboisière, Institut Fédératif de Recherche "Circulation, Paris 7", Paris, France.
authors.forename: J S
authors.initials: JS
authors.lastname: Silvestre
authors.forename: Z
authors.initials: Z
authors.lastname: Mallat
authors.forename: M
authors.initials: M
authors.lastname: Duriez
authors.forename: R
authors.initials: R
authors.lastname: Tamarat
authors.forename: M F
authors.initials: MF
authors.lastname: Bureau
authors.forename: D
authors.initials: D
authors.lastname: Scherman
authors.forename: N
authors.initials: N
authors.lastname: Duverger
authors.forename: D
authors.initials: D
authors.lastname: Branellec
authors.forename: A
authors.initials: A
authors.lastname: Tedgui
authors.forename: B I
authors.initials: BI
authors.lastname: Levy
mesh_terms: D000818:Animals; D001160:Arterioles / Q000502:physiology; D002196:Capillaries / Q000502:physiology; D018076:DNA, Complementary / Q000235:genetics; D016228:Endothelial Growth Factors / Q000378:metabolism; D018014:Gene Transfer Techniques; D006614:Hindlimb / Q000098:blood supply*; D016753:Interleukin-10 / Q000235:genetics / Q000378:metabolism*; D007511:Ischemia / Q000235:genetics / Q000503:physiopathology*; D017078:Laser-Doppler Flowmetry; D008222:Lymphokines / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018482:Muscle, Skeletal / Q000378:metabolism; D018919:Neovascularization, Physiologic; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D018076:DNA, Complementary; D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016753:Interleukin-10